Pulmonary Pharmacology & Therapeutics

Papers
(The H4-Index of Pulmonary Pharmacology & Therapeutics is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Celebrating the appointment of Mario Cazzola as Honorary Editor of Pulmonary Pharmacology & Therapeutics42
Improvement of asthma control in adult patients using extrafine inhaled beclomethasone/formoterol fixed combination as maintenance therapy as well as maintenance and reliever therapy – CONTROL study39
Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)31
Echocardiographic effects of dupilumab in patients with severe type 2 asthma28
Shedding light on vitamin D in tuberculosis: A comprehensive review of clinical trials and discrepancies26
Evaluation of body weight–based dosing, alternative dosing regimens, and treatment interruptions for α1-proteinase inhibitors and implications on biochemical efficacy in patients with α1-antitrypsin d25
Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients22
Editorial Board20
S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function20
Editorial Board19
Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation19
Pharmacokinetic variability of CFTR modulators from standard and alternative regimens19
Editorial Board18
Chronic obstructive pulmonary disease and emerging ER stress-related therapeutic targets17
Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential16
Exploring the role of β2- and β3-adrenergic receptors in cystic fibrosis15
Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment15
0.49212312698364